Clive Brown
Chief Tech/Sci/R&D Officer chez OXFORD NANOPORE TECHNOLOGIES PLC
Fortune : 3 M $ au 31/03/2024
Profil
Clive G. Brown occupe le poste de directeur de la technologie et de directeur chez Oxford Nanopore Technologies Plc. Dans le passé, M. Brown a occupé le poste de directeur des technologies de l'information chez Solexa Ltd, de directeur principal chez Oxford GlycoSciences Plc, de consultant au Wellcome Trust Sanger Institute et de consultant chez Glaxo Wellcome, Inc. Clive G. Brown a obtenu un diplôme de premier cycle à l'université de York.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/01/2024 | 1 720 213 ( 0,20% ) | 3 M $ | 31/03/2024 |
Postes actifs de Clive Brown
| Sociétés | Poste | Début |
|---|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Chief Tech/Sci/R&D Officer | 01/07/2008 |
Anciens postes connus de Clive Brown
| Sociétés | Poste | Fin |
|---|---|---|
| The SCO Group Ltd. | Director/Board Member | - |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Corporate Officer/Principal | - |
Solexa Ltd.
 Solexa Ltd. Medical SpecialtiesHealth Technology Solexa Ltd. was a developer of instruments for analyzing genes in the process of drug development. It's research methods have included DNA sequencing, gene expression, genotyping and micro-RNA analysis to allow scientists to analyze individual genomes for drug development and personalized medicine. The company was headquartered in Saffron Walden, UK. | Chief Tech/Sci/R&D Officer | - |
Wellcome Trust Sanger Institute
 Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Clive Brown
| The University of York | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Technology |
| Entreprise privées | 5 |
|---|---|
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
Solexa Ltd.
Solexa Ltd. Medical SpecialtiesHealth Technology Solexa Ltd. was a developer of instruments for analyzing genes in the process of drug development. It's research methods have included DNA sequencing, gene expression, genotyping and micro-RNA analysis to allow scientists to analyze individual genomes for drug development and personalized medicine. The company was headquartered in Saffron Walden, UK. | Health Technology |
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
| The SCO Group Ltd. |
